These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33242138)

  • 21. Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer.
    Jethwa KR; Jang S; Mullikin TC; Harmsen WS; Petersen MM; Olivier KR; Park SS; Neben-Wittich MA; Hubbard JM; Sandhyavenu H; Whitaker TJ; Waltman LA; Kipp BR; Merrell KW; Haddock MG; Hallemeier CL
    Radiother Oncol; 2020 May; 146():29-36. PubMed ID: 32114263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa RJM; Palma DA
    Lancet Oncol; 2021 Jan; 22(1):6-8. PubMed ID: 33387496
    [No Abstract]   [Full Text] [Related]  

  • 23. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Best of the Radiosurgery Society® Scientific Meeting 2014: stereotactic radiosurgery/stereotactic body radiotherapy treatment of extracranial and intracranial lesions.
    Mahadevan A; Bucholz R; Gaya AM; Kresl JJ; Mantz C; Minnich DJ; Muacevic A; Medbery C; Yang J; Caglar HB; Davis JN
    Future Oncol; 2014 Dec; 10(15):2307-10. PubMed ID: 25525840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
    Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.
    De Rose F; Cozzi L; Navarria P; Ascolese AM; Clerici E; Infante M; Alloisio M; Testori A; Toschi L; Finocchiaro G; Santoro A; Scorsetti M
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):13-20. PubMed ID: 26385822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
    Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
    Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
    Bates JE; Choi G; Usuki KY; Katz AW; Milano MT
    Am J Clin Oncol; 2018 Dec; 41(12):1172-1175. PubMed ID: 29664795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiotherapy in oligometastatic cancer.
    Kennedy TAC; Corkum MT; Louie AV
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
    De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
    Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT
    Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
    Pasqualetti F; Montrone S; Vivaldi C; Zani M; Fedele D; Fornaro L; Pasqualetti G; Salvatore L; Manfredi B; Laliscia C; Coraggio G; Gonnelli A; Loupakis F; Masi G; Sainato A; Monzani F; Falcone A; Paiar F
    Anticancer Res; 2017 Jan; 37(1):315-319. PubMed ID: 28011508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
    J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
    Bernard V; Bishop AJ; Allen PK; Amini B; Wang XA; Li J; Tatsui CE; Rhines LD; Brown PD; Ghia AJ
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1207-1215. PubMed ID: 29029886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary: Simple math is not so straightforward with stereotactic body radiotherapy for colorectal carcinoma metastases.
    Gray WH; Atay SM; Kim AW
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1242-1243. PubMed ID: 31101346
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
    Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
    Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease.
    Van den Begin R; Engels B; Collen C; de Vin T; Defauw A; Dubaere E; Barbé K; De Ridder M
    Radiother Oncol; 2019 Apr; 133():113-119. PubMed ID: 30935566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
    Guerrero E; Ahmed M
    Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.